ID   YTC3
AC   CVCL_A1JP
SY   YT-C3
DR   Wikidata; Q102115152
RX   PubMed=1313126;
RX   PubMed=2578514;
RX   PubMed=8217217;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1797 ! YT
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
RX   PubMed=1313126;
RA   Yoneda N., Tatsumi E., Kawano S., Teshigawara K., Oka T., Fukuda M.,
RA   Yamaguchi N.;
RT   "Detection of Epstein-Barr virus genome in natural-killer-like cell
RT   line, YT.";
RL   Leukemia 6:136-141(1992).
//
RX   PubMed=2578514; DOI=10.4049/jimmunol.134.3.1623;
RA   Yodoi J., Teshigawara K., Nikaido T., Fukui K., Noma T., Honjo T.,
RA   Takigawa M., Sasaki M.S., Minato N., Tsudo M., Uchiyama T., Maeda M.;
RT   "TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2
RT   receptor on a natural killer-like cell line (YT cells).";
RL   J. Immunol. 134:1623-1630(1985).
//
RX   PubMed=8217217; DOI=10.3109/08977199309010829;
RA   Nazarea M., Saito Y., Okazaki S., Suzuki N., Honjo T.;
RT   "A monoclonal antibody which inhibits growth of T cell lines.";
RL   Growth Factors 9:139-147(1993).
//